HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum ghrelin levels in patients with Behcet's disease.

AbstractINTRODUCTION:
Behcet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology.
AIM:
To measure serum ghrelin levels in BD patients and healthy controls and to investigate its association with metabolic syndrome (MetS).
MATERIAL AND METHODS:
Thirty BD patients and 30 healthy individuals were enrolled in the study. Ghrelin levels were measured in blood samples using ELISA.
RESULTS:
The mean serum ghrelin level in BD patients (28.57 ±14.04) was significantly lower compared to healthy controls (40.72 ±23.21) (p = 0.01). The mean serum ghrelin level in BD patients who had MetS (24.18 ±12.73) was lower compared to BD patients who did not have MetS (30.77 ±14.45), but this difference was not significant (p > 0.05).
CONCLUSIONS:
Ghrelin levels were lower in BD patients compared to healthy controls. There was no association between reduced ghrelin levels and MetS; however, there was a negative correlation between ghrelin levels and disease activity.
AuthorsIlker Erden, Haydar Uçak, Betül Demir, Demet Cicek, Selma Bakar Dertlioğlu, Suleyman Aydin, Savas Ozturk
JournalPostepy dermatologii i alergologii (Postepy Dermatol Alergol) Vol. 33 Issue 6 Pg. 450-456 (Dec 2016) ISSN: 1642-395X [Print] Poland
PMID28035223 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: